Unicycive Therapeutics, Inc.

NASDAQ:UNCY

0.4347 (USD) • At close October 21, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 00-0.271000.67500.95100000000000000
Kosten van de omzet 00.2840.0820.0790.0780.0450.0020.0010.0020.0020.00100000000000
Brutowinst 0-0.284-0.353-0.079-0.0780.63-0.0020.95-0.002-0.002-0.00100000000000
Brutowinstmarge 001.303000.93300.99900000000000000
Onderzoek- en ontwikkelingskosten 4.8686.8134.2333.3722.2673.033.844.8031.861.9331.3613.7760.4930.450.3820.3040.1820.1480.3760.1880.1160.116
Algemene en administratieve kosten 2.5332.3912.082.5662.0551.8471.4851.7021.7761.6041.3910.9390.2860.2810.3350.3220.1540.1940.3250.2930.2750.275
Verkoop- en marketingkosten 0-0.284-0.0820000000000000000000
Verkoop-, algemene en administratieve kosten 2.5332.1071.9982.5662.0551.8471.4851.7021.7761.6041.3910.9390.2860.2810.3350.3220.1540.1940.3250.2930.2750.275
Overige kosten 0000000000000000000000
Bedrijfskosten 7.4018.926.2315.9384.3224.8775.3256.5053.6363.5372.7524.7150.7790.7310.7170.6260.3360.3420.7010.5440.3910.391
Bedrijfsresultaat -7.401-9.204-6.313-5.938-4.322-4.202-5.325-5.554-3.636-3.537-2.752-4.715-0.779-0.731-0.717-0.626-0.336-0.342-0.701-0.481-0.391-0.391
Bedrijfsresultaat ratio 0023.29500-6.2250-5.8400000000000000
Totaal overige inkomsten en kosten netto 17.256-11.759-1.4851.5330.282-10.373-0.003-0.003000-0.431-0.3210.019-0.163-0.076-0.002-0.002-0.001-0.083-0.059-0.059
Inkomen voor belasting 9.855-20.963-7.798-4.405-3.838-14.575-5.328-5.557-3.636-3.537-2.752-5.201-1.1-0.964-0.88-0.702-0.338-0.344-0.702-0.564-0.45-0.45
Inkomen voor belasting ratio 0028.77500-21.5930-5.84300000000000000
Belastingkosten 5.9250.241-10.53-0.0790.03210.5770.0030.0030.0380.037-0.4120.431-0.779-0.019-0.717-0.626-0.336-0.342-0.001-0.083-0.059-0.059
Nettowinst 3.93-20.963-7.798-4.405-3.838-25.152-5.331-5.56-3.636-3.537-2.752-5.201-1.1-0.964-0.88-0.702-0.338-0.344-0.702-0.564-0.45-0.45
Nettowinstmarge 0028.77500-37.2620-5.84600000000000000
WPA (Winst Per Aandeel) 0.08-0.6-0.22-0.13-0.25-1.65-0.35-0.37-0.24-0.24-0.19-0.37-0.079-0.11-0.061-0.083-0.04-0.024-0.084-0.069-0.057-0.057
Verwaterde WPA 0.08-0.6-0.22-0.13-0.25-1.65-0.35-0.37-0.24-0.24-0.19-0.37-0.079-0.11-0.061-0.082-0.039-0.024-0.084-0.069-0.057-0.057
EBITDA -7.401-8.92-6.231-5.938-4.01-4.143-5.283-5.514-3.596-3.498-2.752-4.715-0.779-0.731-0.717-0.626-0.336-0.342-0.001-0.083-0.059-0.059
EBITDA ratio 0022.99300-6.1380-5.79800000000000000